← Browse by Condition
Medical Condition
renal cell carcinoma metastatic
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 3
ClinicalMetric tracks all active clinical trials for renal cell carcinoma metastatic sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — renal cell carcinoma metastatic Clinical Trials
How many clinical trials are currently recruiting for renal cell carcinoma metastatic?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for renal cell carcinoma metastatic, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for renal cell carcinoma metastatic?
renal cell carcinoma metastatic research spans Phase 1 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a renal cell carcinoma metastatic clinical trial?
Eligibility criteria for renal cell carcinoma metastatic trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06321250 Phase 1
Recruiting
A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma
Enrollment
80 pts
Location
China
Sponsor
Jemincare
NCT06995664
Recruiting
Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management
Enrollment
24 pts
Location
United Kingdom
Sponsor
Royal Marsden NHS Foundation T...
NCT05548621
Recruiting
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
Enrollment
180 pts
Location
Netherlands
Sponsor
St. Antonius Hospital
NCT06726421 Phase 3
Recruiting
Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)
Enrollment
252 pts
Location
China
Sponsor
Sun Yat-sen University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology